RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19: did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death in this clinical context. https://t.co/JYrnjjO6BP
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
(NEJM) Edad >64 años, cardiopatía isquémica, insuficiencia cardíaca, arritmia cardíaca, EPOC y tabaquismo se asociaron a mayor riesgo de muerte entre los pacientes hospitalizados por #Covid19 IECA o ARA2 no (8910 pacientes) https://t.co/DfyDF44eAa
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
Possible pleiotropic effects of statin? #VitaminS Probably a more appropriate place to use the phrase - “..what have we got to loose” instead of with HCQ!
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
"Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated w an increased risk of in-hospital death...Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors"
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @Azeem_Majeed: Another reason to stop smoking. Risk factors for death in hospital patients with Covid-19 in an international study publi…
(NEJM) Ni IECA ni ARA2 se asociaron a mayor riesgo de muerte entre los pacientes hospitalizados con #Covid19 (8910 pacientes) https://t.co/DfyDF44eAa
دراسة بينت ان ادوية الضغط (ACEI/ARB) لا تؤثر على المرضى المصابين بكوفيد ١٩ #لا_توقف_ادوية_الضغط https://t.co/yz6fiJFZWQ
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascular disease is associated with an increased risk of in-hospital death. https://t.co/uy2XcDkrUZ https://t.co/i2QKwTioP9 https://t.co/y4I7k
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
These interesting observational findings from a large, global cohort should help inform how we can optimize the COVID-19 trials portfolio moving forward and ensure we are evaluating therapies with plausible clinical benefits.
Good news, for me and others regarding #ACE and #ARB medications. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM via @JoeriKint https://t.co/CQABxTOS24
@asouth_neph @__philipn__ @Nephro_Sparks
"Is #coronavirus the last proverbial straw that breaks the camel's back"? In #COVID__19 stress of critical illness + inflammation may unite in destabilizing the diseased heart. Vascular endothelial cell dysfunction is also a key villain. @MRMehraMD argues.
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/iN5mVVgq4H
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
Multivariate analsysis of CV risk factors associated with in-hospital COVID 19 deaths. Resurrection of the old pleiotropic effect theory for statins? RCT necessary of course... https://t.co/H4SyfxZ3RR https://t.co/x27r5asYSu
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/kMvK8VFfxV
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/DiwheBz7cR
RT @GermHunterMD: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19 Data from a large observational database (8910 patients…
➡️ 3️⃣ @NEJM studies 1️⃣ conclusion❗ ACEi/ARBs DO NOT increase risk of #COVID19 ❗❗ https://t.co/XgqYG2oebP https://t.co/lXwh4V0xds https://t.co/lXwh4V0xds #coronakidney
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/HxuJqyEnqP
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/Pf5MrtiQXH
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFwbpkM3 https://t.co/mPgYC7srMd Editorial sums it up https://t.co/NwkPXcutdJ https://t.co/zFjCXfoSgE
After months of confusion, anxiety, and hasty decisions among #BloodPressure patients (like me), docs, and scientists, glad that some clarity is finally emerging. No increase in risk with ACE-inhibitors/ARBs in #COVID19. https://t.co/QDdtierPW6 https://t.c
RT @GermHunterMD: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19 Data from a large observational database (8910 patients…
Enfermedad cardiovascular asociada a COVID19 https://t.co/Dko8qsjpdK
RT @GermHunterMD: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19 Data from a large observational database (8910 patients…
RT @ClinpharmZono: やはり、ACE-IやARBは無闇に中止せず継続の方針で良さそうな結果ですね。 https://t.co/VcANGOT8K2
Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19 @NEJM Underlying CV disease is associated with an increased risk of in-hospital death No harmful association of ACE inhibitors or ARBs with in-hospital death https://t.co/AvyJRlyYHv https
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @GermHunterMD: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19 Data from a large observational database (8910 patients…
RT @GermHunterMD: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19 Data from a large observational database (8910 patients…
Les estatines, com alguns altres ja apuntaven, no són mala cosa, en contra del q proposa Ravnskov Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/c6bz1jYdcn
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
Statins and ACE-I associated with decreased mortality for Covid (although CVD itself is risk factor for increased mortality). Difficult to tease out reasons or causality, but it's amazing this has taken 4 months to figure out, but glad there is some more c
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
やはり、ACE-IやARBは無闇に中止せず継続の方針で良さそうな結果ですね。 https://t.co/VcANGOT8K2
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en este grupo de personas. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/1jFgbAQ0qR
No evidence that ACE inhibitors, ARBs, or other antihypertensive medications are associated with increased risk or severity of COVID-19. https://t.co/4JLjghjl6n https://t.co/Rr115PpySV https://t.co/s0Ty7At8mR https://t.co/url0vx2tW6
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
Such an important study. Thank you for this terrific study @MRMehraMD
RT @Azeem_Majeed: Another reason to stop smoking. Risk factors for death in hospital patients with Covid-19 in an international study publi…
RT @Azeem_Majeed: Another reason to stop smoking. Risk factors for death in hospital patients with Covid-19 in an international study publi…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
Another reason to stop smoking. Risk factors for death in hospital patients with Covid-19 in an international study published in @NEJM included age > 65 years, male sex, cardiovascular disease, chronic lung disease and smoking. https://t.co/7hLbeip5cp h
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
#Cardiovascular disease associated with increased risk of death in patients hospitalized with #COVID__19 https://t.co/IqF9s6GUma
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
NEJM: ACE inhibitor use appears uncorrelated w covid-19 mortality https://t.co/Pu7ai7puJA
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/9xYqsHEY9n
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…